Become a partner

Pharmacy Plus Health Limited

Digital Strength: Emerging Rank: #10 in West Yorkshire Turnover: £23.4m

Sample request and response

GET https://api.archive.partners/v1/marketintel/benchmark/companies/14443321?fields[]=introduction&fields[]=regional_footprint

{
  "company_id": "14443321",
  "company_name": "Pharmacy Plus Health Limited",
  "county": "West Yorkshire",
  "county_rank": 10,
  "turnover_millions": 23.4,
  "digital_strength": "Emerging",
  "search_footprint": 10,
  "postcode": "LS15 0BF",
  "fields": {
    "introduction": "Add fields[]=introduction to return.",
    "regional_footprint": "Add fields[]=regional_footprint to return.",
    "digital_benchmark": "Add fields[]=digital_benchmark to return.",
    "financial_health_signals": "Add fields[]=financial_health_signals to return.",
    "watchlist_signals": "Add fields[]=watchlist_signals to return.",
    "market_outlook": "Add fields[]=market_outlook to return."
  }
}

Introduction

Pharmacy Plus Health Limited serves as a mid-tier contributor within the local economy, holding a firm position as the tenth-ranked entity among our monitored cohort in West Yorkshire. With their legal standing formalised under the Pharmacy Plus Health Limited Companies House registration 14443321, the firm currently occupies a transitional phase defined as an emerging digital operator. This classification suggests a business that has moved beyond initial startup volatility but is now navigating the complexities of scaling operational infrastructure. Our platform identifies this positioning as a pivotal juncture for stakeholders evaluating the firm’s long-term sustainability and regional integration.

Regional Footprint

The economic impact of this entity is significant when measured against the broader industrial landscape of the region. Generating a turnover of £23.4 million, the firm commands a 3.0% share of the total £786.6 million monitored output across our West Yorkshire dataset. For a business operating at this scale, such a contribution implies a robust supply chain footprint and a likely employment tier that supports dozens of local livelihoods. As an emerging-digital participant, their capacity to maintain this output level indicates efficient resource management and a stable presence within the competitive West Yorkshire business financial performance ecosystem.

Digital Benchmark

The digital presence of the company is currently aligned with the average performance metrics observed across our monitored portfolio. Being broadly in line with the regional benchmark suggests that the firm meets standard expectations for accessibility and information disclosure, which is a reassuring indicator for procurement teams and ESG auditors. While their digital strategy is not yet disruptive, this level of consistency serves as a proxy for operational stability. For those conducting due diligence regarding West Yorkshire company digital compliance, this neutral positioning implies a predictable regulatory posture that neither raises red flags nor necessitates aggressive corrective oversight.

Financial Health Signals

While raw registration data provides a static overview, our proprietary analysis of Archive Partners West Yorkshire intelligence suggests a more nuanced profile for this entity. The presence of ten indexed search signals indicates a level of market visibility that effectively reduces informational opacity, a key metric for credit risk assessments. By cross-referencing these signals against standard filing cadences, we can assess governance quality more accurately than a basic lookup would permit. This transparency acts as a defensive layer, suggesting that the firm is actively engaging with the commercial environment rather than operating in relative isolation.

Watchlist Signals

For fund analysts and procurement leads, ongoing monitoring is essential to distinguish between organic growth and potential volatility. Primary watchpoints should include the cadence of statutory filings, any abrupt shifts in director mandates, and the trajectory of their digital footprint. Any deviation from established filing timelines should be treated as a potential indicator of internal structural pressure. Furthermore, observing the company’s movement relative to its SIC-peer group will provide the necessary context to determine whether its current market standing is a byproduct of regional sector tailwinds or specific management decisions requiring deeper scrutiny.

Market Outlook

Looking toward the next twenty-four months, the firm faces a landscape defined by both consolidation and digital transformation imperatives. As it matures, the transition from an emerging digital state to a more integrated model will be the primary driver of its valuation and creditworthiness. Subscribers should prioritize the upcoming filing cycle to confirm that revenue growth remains in line with regional benchmarks. Given the firm’s current ranking, a signal-based recommendation suggests maintaining a watchful but optimistic posture, provided that the company demonstrates continued commitment to data transparency and consistent financial reporting as it scales operations.

All data is based on the latest digital audit and is subject to change without notice. Rankings and scores are updated periodically as new regulatory and web intelligence signals are processed. To report a data discrepancy, please contact our support team.

Claim this profile to manage Pharmacy Plus Health Limited’s compliance record, respond to signals, and add verified contact details.